Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015
Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy Source: Eur Respir J 2015; 46: 554-557 Year: 2015
Detection of antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in children and adults with cystic fibrosis (CF) Source: Eur Respir J 2007; 30: Suppl. 51, 648s Year: 2007
Antineutrophil cytoplasmic antibodies (ANCA) and antinuclear antibodies (ANA) in cystic fibrosis (CF) Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004
Antineutrophil cytoplasmic antibody (ANCA) associated lung-renal vasculitides: A single centre perspective Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012
Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018
Cystic lesion in myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)- positive interstitial pneumonia: radiological and pathological anaylsis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018
ANCA (antineutrophil cytoplasmic autoantibody) in the chronic lower respiratory tract infection Source: Eur Respir J 2002; 20: Suppl. 38, 444s Year: 2002
Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020
Specific IgG antibodies in chronic hypersensitivity pneumonitis Source: International Congress 2015 – IIPs: orphan Year: 2015
Liposomal local therapy of upper respiratory tract involvement in ANCA associated vasculitis Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014
Non- cystic fibrosis bronchiectasis in primary antibody deficiency patients Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014
The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis Source: Eur Respir J 2011; 37: 1503-1513 Year: 2011
Lung involvement in ANCA associated crescentic glomerulonephritis Source: Eur Respir J 2005; 26: Suppl. 49, 31s Year: 2005
Silicosis, asbestosis and ANCA positivity Source: Eur Respir J 2001; 18: Suppl. 33, 437s Year: 2001
Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis Source: Eur Respir J 2009; 34: 1079-1085 Year: 2009
Pulmonary manifestations of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)-related systemic vasculitis:CT findings in 50 patients Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002
Anti-neutrophil cytoplasmic antibodies and immune complexes vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=91 Year: 2005
Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005
Anti-endothelial cell antibodies in patients with idiopathic nonspecific interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 308s Year: 2006